Play
SBIOS
Decoding biology. Advancing healthcare.
Welcome to SBIOS, a pioneer in genomics
and biomarker innovation. We specialize in
decoding the complexities of human biology
to advance personalized medicine, diagnostics,
and therapeutic development. Partner with us
to shape the future of genomics and healthcare.
Our Products
Genomic Analysis
Our advanced genomic analysis platform enables comprehensive DNA sequencing, variant calling, and interpretation to identify genetic factors in diseases and treatment responses.
Learn MoreBiomarker Discovery
Our biomarker discovery tools help identify novel molecular indicators for disease diagnosis, prognosis, and treatment response prediction using multi-omics data integration.
Learn MoreCustom Solutions
We develop tailored bioinformatics and genomics solutions for pharmaceutical research, clinical trials, and precision medicine applications based on your specific requirements.
Learn More
Our Research
We have developed a state-of-the-art model that identifies novel biomarkers to predict the response of drugs after short-term treatment for cancer, which aims to investigate the association between treatment response and genomics modules and uncover key biological processes and pathways in cancer.
Publications & Articles
- Protein Levels of the gp78 Ligase Predict Poor Breast Cancer Outcome Based on Race. The Journal of Clinical Investigation (JCI) Insight, May 2022, (PMC9310521)
- Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival. Nature - Communications biology 4 (1), 1-132021
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature genetics 53 (1), 65-75
- Ancestry-dependent gene expression correlates with reprogramming to pluripotency and multiple dynamic biological processes. Sci Adv. 2020 Nov;6(47). doi: 10.1126/sciadv.abc3851. Print 2020 Nov. PubMed PMID: 33219026; PubMed Central PMCID: PMC7679169
- Racial Differences in the Association between Luminal Master Regulator Expression and Breast Cancer Survival". Clinical Cancer Research, 2020
- Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis, "Journal of Clinical Oncology, 2012J Clin Oncol 30:1996-2004, 2012
- Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling, "Clinical Cancer Research, 2012
Individual Affiliated Publications
Contact Us
Get in Touch
Ready to partner with us? Our team is available to discuss your genomics and biomarker needs.
Grand Forks, North Dakota